
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation Langfristige Verbindlichkeiten 2011-2026 | NVTA
Langfristige Verbindlichkeiten Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 320 M | 84.8 M | 55.9 M | 16.8 M | 7.42 M | 205 M | 88.2 M | 37.6 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 320 M | 7.42 M | 102 M |
Langfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
3.29 B | $ 116.92 | 2.67 % | $ 35.5 B | ||
|
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | ||
|
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | ||
|
BioNano Genomics
BNGO
|
16.4 M | $ 1.18 | 0.85 % | $ 6.43 M | ||
|
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | ||
|
Interpace Biosciences
IDXG
|
10 M | $ 1.98 | -0.63 % | $ 8.76 M | ||
|
CareDx, Inc
CDNA
|
17.9 M | $ 17.92 | 1.41 % | $ 955 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M | ||
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M | ||
|
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | ||
|
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 16.24 | 0.93 % | $ 175 M | ||
|
Co-Diagnostics
CODX
|
574 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
2.76 M | $ 25.19 | 1.45 % | $ 700 M | ||
|
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
2.35 B | $ 175.07 | 3.26 % | $ 8.68 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | ||
|
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | ||
|
Danaher Corporation
DHR
|
26.9 B | $ 196.19 | 2.71 % | $ 140 B | ||
|
OpGen
OPGN
|
21.2 M | - | -16.95 % | $ 1.54 M | ||
|
PerkinElmer
PKI
|
2.96 B | - | -0.91 % | $ 14.7 B | ||
|
Twist Bioscience Corporation
TWST
|
4.56 M | $ 51.17 | 2.09 % | $ 3.06 B | ||
|
Fulgent Genetics
FLGT
|
2.26 M | $ 15.83 | -0.5 % | $ 479 M | ||
|
Quotient Limited
QTNT
|
201 M | - | -11.32 % | $ 1.1 M | ||
|
Guardant Health
GH
|
91.4 M | $ 92.84 | -0.49 % | $ 11.6 B | ||
|
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
4.17 M | $ 2.73 | 1.49 % | $ 88.6 K | ||
|
Biomerica
BMRA
|
1.57 M | $ 2.15 | -0.46 % | $ 4.94 M | ||
|
ICON Public Limited Company
ICLR
|
461 M | $ 106.54 | -0.58 % | $ 8.79 B | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
Illumina
ILMN
|
2.04 B | $ 128.0 | 1.23 % | $ 20.4 B | ||
|
Celcuity
CELC
|
69.2 K | $ 116.94 | 1.19 % | $ 5.47 B | ||
|
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 274.72 | 2.06 % | $ 22.9 B | ||
|
Lantheus Holdings
LNTH
|
225 M | $ 80.03 | 2.5 % | $ 5.4 B | ||
|
Medpace Holdings
MEDP
|
73.8 M | $ 520.65 | 2.39 % | $ 15 B | ||
|
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 198.81 | 1.02 % | $ 22.1 B | ||
|
Myriad Genetics
MYGN
|
107 M | $ 4.77 | 0.63 % | $ 442 M | ||
|
NeoGenomics
NEO
|
435 M | $ 8.22 | 1.99 % | $ 1.05 B | ||
|
Neogen Corporation
NEOG
|
19.6 M | $ 10.34 | 3.61 % | $ 2.24 B | ||
|
ENDRA Life Sciences
NDRA
|
843 K | $ 5.17 | -3.18 % | $ 4.07 M | ||
|
National Research Corporation
NRC
|
39.6 M | $ 17.26 | 1.29 % | $ 386 M | ||
|
Natera
NTRA
|
124 M | $ 210.83 | 0.75 % | $ 20.7 B |